Pluripotency of mesenchymal stem cells derived from adult marrow

By Yuehua Jiang, B. Jahagirdar, R. Reinhardt, R. Schwartz, C. Keene, Xilma R. Ortiz-González, M. Reyes, T. Lenvik, T. Lund, M. Blackstad and 6 more. Nature, 2002

2,816 citations recorded by the source corpus.

Subfields: Genetics, Molecular Biology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/25563145cb1794662a75a272075ce4511c060023

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Genetics

1. Jennifer Nichols
2. Ian Chambers
3. S. Sell
4. M. C. Simon
5. Austin G Smith
6. B. Keith
7. S. Yamanaka
8. P. Labosky

In Molecular Biology

1. Jennifer Nichols
2. S. Yamanaka
3. Austin G Smith
4. M. C. Simon
5. Ian Chambers
6. B. Keith
7. Cheng-Jun Hu
8. John D. Gordan

In Pulmonary and Respiratory Medicine

1. S. Sell
2. M. C. Simon

Citations in the corpus

• Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. (2003, background): “It will be of interest to determine whether Nanog is expressed in multipotent adult progenitor cells (Jiang et al., 2002) and may therefore be generally associated with pluripotency, or whether it is truly unique to the ES cell phenotype.”
• Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. (2005, methodology): “BMMSC-M1 and AT-MSC-M1 were isolated in the same culture medium (M1) with low serum content (2% FCS) as described by the group of Catherine Verfaillie for the isolation of MAPC [3,21].”
• Stem cell origin of cancer and differentiation therapy. (2004, background): “Regardless if there is a single pleopotent cells or multiple stem cells with different potential, the putative stem cells arising from the bone marrow of adults may have just as much promise as embryonic stem cells for stem cell therapy [213–215].”